ArticleMethods in molecular biology (Clifton, N.J.)2026
Artificial Intelligence Applications in Bacteriophage Genomics and Host Interaction.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antibiotic-resistant bacterial infections remain a major public health challenge, contributing to an estimated 1.27 million deaths in 2019. Pathogens, such as Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii, cause a range of infections in clinical and food environments. As these bacteria rapidly develop resistance to multiple antibiotics, there is a growing need for alternative treatments. One promising approach is bacteriophage (phage) therapy. Phages are bacterial viruses that recognize, infect, and kill their hosts to propagate. Their relatively low isolation and production costs make them attractive antibacterial agents. However, unlike antibiotics, their host specificity requires individualized testing to identify effective phages, typically through plaque assays. This labor-intensive and time-consuming method limits the scalability of phage therapy, especially for large phage libraries. With the remarkable advances in genome sequence technologies over the past years, a vast and highly diverse set of phage genomes have been sequenced at decreasing costs. This growing volume of genomic data has enabled the application of Artificial Intelligence (AI), particularly Machine Learning (ML), and its subfield Deep Learning (DL) in phage research. Data-driven approaches are increasingly used for genome annotation, host prediction, lifestyle classification, and the identification of therapeutic candidates, offering scalable alternatives to traditional methods. Despite the availability of numerous genome annotation tools, only a limited number are specifically tailored to phage genomes. Phage infectivity, determined by host range, arises from complex interactions between the phage and its host at both extracellular and intracellular levels. Extracellularly, successful infection depends on the phage's ability to recognize and bind to host receptors. Intracellularly, bacteria have evolved a variety of innate and adaptive defense systems to prevent phage replication. To better understand these interactions, several computational tools have been developed to detect and characterize phage-host interactions. A comprehensive understanding of phage-host dynamics, both extracellular and intracellular level, is critical for advancing predictive models and facilitating the clinical translation of phage therapy.
Indexed as
Identifiers
42681003What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.